People: IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

121.78USD
15 Sep 2014
Price Change (% chg)

$-1.90 (-1.54%)
Prev Close
$123.68
Open
$122.90
Day's High
$123.08
Day's Low
$120.75
Volume
121,525
Avg. Vol
123,775
52-wk High
$140.00
52-wk Low
$96.61

Search Stocks

Junius, Daniel 

Brief Biography

Mr. Daniel M. Junius is an Independent Director of IDEXX Laboratories, Inc. Mr. Junius has served as President and Chief Executive Officer of ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapeutics, since January 2009. Prior to that, he served as President and Chief Operating Officer and Acting Chief Financial Officer of ImmunoGen from July 2008 to December 2008, as Executive Vice President and Chief Financial Officer from 2006 to July 2008, and as Senior Vice President and Chief Financial Officer from 2005 to 2006. Mr. Junius has also served as a director of ImmunoGen since November 2008. Before joining ImmunoGen, Mr. Junius was Executive Vice President and Chief Financial Officer of New England Business Service, Inc. (NEBS), a business to business direct marketing company, from 2002 until its acquisition by Deluxe Corporation in 2004 and Senior Vice President and Chief Financial Officer of NEBS from 1998 to 2002. Prior to NEBS, he was Vice President and Chief Financial Officer of Nashua Corporation, a manufacturer and marketer of specialty imaging paper and label products and services. He joined Nashua Corporation in 1984 and held financial management positions of increasing responsibility before becoming Chief Financial Officer of that company in 1996. Mr. Junius holds a Bachelor of Arts in Political Science from Boston College and a Masters in Management from Northwestern University's Kellogg School of Management.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jonathan Ayers

3,973,980

Brian McKeon

--

Jeffrey Fiarman

--

Jay Mazelsky

2,232,920

Johnny Powers

2,234,880

Michael Williams

2,781,760
As Of 30 Dec 2013
Search Stocks